Tagimmunity

Case report: HIV-associated neurocognitive disorder & myelopathy in patient with preserved CD4, but high viral load

C

HIV-associated neurocognitive disorder and HIV-associated myelopathy in a patient with a preserved CD4, but high viral load-a rarely reported phenomenon: a case report and literature review.  Ayele, B.A., Amogne, W. & Gemechu, L. BMC Infect Dis 20, 574 (2020). This case supports the current understanding regarding the persistent occurrence of HIV-associated neurocognitive disorder and HIV...

Update on COVID-19 for PLHIV

U

SAMESH, March 19, 2020 SAMESH, SHINE SA, and Thorne Harbour Health are encouraging people living with HIV (PLHIV) to take additional precautions in the face of the changing landscape around 2019 novel coronavirus (COVID-19). We want to ensure the ongoing health and wellbeing of all PLHIV who are more vulnerable to COVID-19. This means minimising the risk of exposure to the virus. While everyone...

Hepatitis B testing infographic now available

H

Hepatitis NSW, October 2017 With the increasing visibility of hep B, Hepatitis NSW felt there was a need to make information about hep B testing clearer. It can be a complex subject to grapple with and there’s lots of misinformation and confusion out there. This hep B testing infographic aims to give both doctors and patients a clearer understanding of what tests to do as well as what the test...

Vaccine for Meningitis Shows Some Protection Against Gonorrhea

V

New Zealand Family Planning Some strains of the bacterium that cause gonorrhoea are now resistant to all available antibiotics. With no new drugs on the near horizon, the disease is in desperate need of a vaccine. Our research, published in the Lancet medical journal this week, shows that protection against gonorrhoea could come from an unexpected source – a vaccine against meningococcal...

‘Shock and kill’ therapy offers fresh hope for HIV cure, researchers say

PBS Newshour, December 15, 2016 at 11:00 AM EST A new small-scale human trial of the promising “shock and kill” treatment is starting this week in New York and two sister sites, in Germany and Denmark.  Another small human study will start in January, followed by a larger human shock and kill trial in June. The HIV research community is increasingly optimistic about this approach to eradicating...

HIV vaccine research: Adelaide team achieves ‘glimpse in right direction’

H

ABC News, 21.11.16
Progress toward vaccinating people against HIV infection has been announced by Adelaide researchers.
A team from the University of Adelaide and the Basil Hetzel Institute at Adelaide’s Queen Elizabeth Hospital used a combined vaccination approach, researcher Dr Branka Grubor-Bauk explained.

Read more here
Access article in Nature Scientific Reports (open access) here

Welcome to SASHA

SASHA is a current awareness service with news and views on various aspects of sexual health and sexuality, from a wide range of sources. These range from credible sources of sexual health and related information, to relevant opinion pieces in the media.

Categories